From the Boston Globe to the New York Times, NPR to the BBC, members of the BU community often find themselves in front of the television camera, radio microphone, or reporter’s notebook.
| Links compiled by Public Relations
A legal grey area is being blamed for an ongoing deadly meningitis outbreak that has seen more than 20 deaths and thousands of people potentially exposed after a tainted drug for back pain was shipped to hospitals and clinics around the country. Critics say drug manufacturers are skirting regulations by classifying themselves as pharmacies, which are freer to mix drug compounds for patients. “It’s just a classic gap in the regulatory structure that companies have used to build this business over the past few decades,” says Kevin Outterson, a professor of health law at the School of Law.
The latest Newsmakers can be found here.
NPR “All Things Considered”
Meningitis Outbreak Puts Doctors, Regulators in New Territory
Calls for more US oversight after tainted drug outbreak
The Meningitis Outbreak: What Can Compounding Pharmacies Do Next?
One woman’s fight for compounding pharmacy guidelines
Critics: Obama shares outbreak blame
Broadside: Lack of oversight?
Fungal meningitis outbreak spreads
Court to hear patient records case
PBS News Hour
Tainted Steroid Drugs Caused Deadly Meningitis Outbreak
Meningitis outbreak: Your questions answered
New York Times
Scant Oversight of Drug Maker in Fatal Meningitis Outbreak